Nostetta Ventures

Nostetta Ventures Oy is a venture capital investor based in Kuopio, Finland, that makes equity investments in early-stage companies. It builds co-investment syndicates through its networks to finance investee companies. The parent group, Nostetta Oy, has focused on early-stage companies since 2013.

The company manages the North Savo Startup Fund in Northern Savo and the South Karelia Growth Fund in South Karelia, with a combined fund size stated as 13.5 M€. It targets early-stage companies with strong growth potential and a clear wish to enter international markets. One investee is Marginum, whose HIVEN® technology helps surgeons distinguish cancerous tissue from healthy tissue in real time during brain surgery; Nostetta Ventures was its first investor.

The company was founded in 2019 and is headquartered in Kuopio. It has no other offices stated. Its stated focus is supporting the emergence of internationally growing companies in Eastern Finland.

Product: Equity investments and co-investment syndicates in early-stage companies, managed through regional funds in Northern Savo and South Karelia.